← Back to Search

Behavioral Intervention

Self-Directed Group for Autism

N/A
Waitlist Available
Led By Brooke Ingersoll, PhD
Research Sponsored by Michigan State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
a DSM-V-informed clinical diagnosis of Autism Spectrum Disorder based on the Autism Diagnostic Observation Schedule (ADOS)
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 1, month 5, & month 8
Awards & highlights

Study Summary

This trial will examine the effect of a new online parent training intervention for children with ASD, comparing the benefits of the self-directed and therapist-assisted delivery formats.

Eligible Conditions
  • Autism
  • Autism Spectrum Disorder

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 1, month 5, & month 8
This trial's timeline: 3 weeks for screening, Varies for treatment, and month 1, month 5, & month 8 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
ImPACT Online Fidelity Change Scale
ImPACT Online electronic tracking system
Intervention Log Change
+5 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Therapist-Assisted GroupExperimental Treatment1 Intervention
Participants assigned to the therapist-assisted group will be given access to the ImPACT Online web-based program for four months and will be encouraged to work through the program at the same pace as the self-directed group. Participants will also receive 2, 30-minute remote coaching sessions per week (24 total sessions) via video conferencing software by a trained therapist to assist them in learning the intervention. The first coaching session of the week will involve the coach and participant and will be used to help clarify the content of the relevant lesson and help the participant apply the lesson content to their own child. The second coaching session of the week will involve the coach, participant, and child and will be used to provide the participant with "live" feedback on their use of the intervention techniques as they practice with their child.
Group II: Self-Directed GroupExperimental Treatment1 Intervention
Participants assigned to the self-directed group will receive access to the secure, password-protected, ImPACT Online web-based program for four months. The web application contains 12, self-directed lessons, each of which takes approximately 75 minutes to complete. Participants will be encouraged to complete one lesson per week and to practice the intervention techniques with their child between each lesson. Each lesson consists of a Narrated Slideshow with embedded video clips, a Written Manual, a self-check quiz, short interactive exercises, a Homework Plan, and reflection questions. Participants in the self-directed group may contact project staff via phone or email for assistance with technology-related problems (e.g., difficulty with logins, problems playing video). However, they will receive no assistance or support in learning the intervention from project staff outside of the self-directed web-based program.
Group III: Web-Based Information Control GroupActive Control1 Intervention
Participants assigned to the web-based information control group will be given access the Resources page with links to the same ASD information websites, but will not receive access to other aspect of the ImPACT Online program. This condition will be used to control for participant maturation as well as the potentially confounding effect of having access to autism-related information via the internet.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
ImPACT Online
2016
N/A
~400

Find a Location

Who is running the clinical trial?

Michigan State UniversityLead Sponsor
184 Previous Clinical Trials
601,362 Total Patients Enrolled
Brooke Ingersoll, PhDPrincipal Investigator - Michigan State University
Michigan State University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~6 spots leftby Apr 2025